Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hearing Aid Maker Eargo Target Of US DOJ Investigation

Executive Summary

Directly billing insurers for over-the-counter hearing aids may have triggered federal concern, a financial analysis firm says.

You may also be interested in...



Eargo To Pay $34M+ To Resolve False-Claims Allegations

The company, which denies the allegations, allegedly sold hearing aids to federal employees and billed  a government insurance plan without the required hearing assessment.

Sweeping Executive Order Puts Hearing Aids Over The Counter; Cracks Down On Internet Providers

The Biden administration wants to make hearing aids less expensive and more readily available – and seeks the same for internet service and prescription drugs.

New Warning Label Added To AFX2 Endovascular Graft

The US FDA released updated safety information on Endologix Inc.’s AFX2 Endovascular abdominal aortic aneurysm (AAA) graft system on Tuesday. Previous devices in the product line have been associated with an increased risk of abnormal bleeding.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144554

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel